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ABSTRACT
Multiple sclerosis (MS) is the most common demyelinating disease of the
central nervous system (CNS) and is becoming an increasing concern for
individuals between the ages of 15 to 50. Multiple sclerosis is a chronic, often
progressive disease that may result in difficulties with vision, verbal
communication, sensation, bowel and bladder function, balance, and ambulation.
The purpose of this study was to determine if significant changes occurred
in static steadiness, symmetry, and dynamic stability in subjects with MS
following a retraining program using the NeuroCom Balance Maste~ (NBM®).
Ten subjects (6 females, 4 males) were placed in a control or treatment group.
The NBM® was used to assess each subject's balance at week one and four,
and was also used in the retraining program for the treatment group three times
per week for four weeks. Results showed a significant difference between
groups in two components of the dynamic stability tests: endpoint excursion
forward (p = .042) and maximum excursion endpoint forward (p = .029). No
significant difference was found in static steadiness or symmetry between
groups.
The variability among subjects in the MS population pool, the small
sample size, and the four-week time frame may have been limiting factors in this
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study, Further research is needed to determine the effectiveness of a balance
retraining program using the NBM®,
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CHAPTER I
INTRODUCTION AND REVIEW OF THE LITERATURE
Multiple sclerosis (MS) is the most common demyelinating disease of the
central nervous system (CNS) and is becoming an increasing concern for
individuals between the ages of 15 to 50. Multiple sclerosis is a chronic, often
progressive disease that may result in difficulties with vision, verbal
communication, sensation, bowel and bladder function, balance and ambulation.
Previous studies have utilized a force platform biofeedback system to assess
and retrain balance in multiple patient populations, including hemiplegia. No
research to date has been conducted utilizing a biofeedback system to assess
and retrain balance of persons with MS.
This paper will provide the reader with a description of the etiology and
associated signs and symptoms of MS as well as the different categories and
course of MS. Diagnosis and treatment of MS will also be covered, with
emphasis placed on the treatment of balance impairments so often associated
with MS. The three systems necessary for adequate postural stability-visual,
vestibular, and somatosensory-will also be discussed.
Multiple Sclerosis
Multiple sclerosis is a chronic, demyelinating disease affecting the white
matter of the central nervous system (CNS).1.s It was described as early as six
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centuries ago and is considered to be the most common disease affecting the
myelin of the CNS. 1 In fact, besides certain mental disorders and neurological
injuries secondary to trauma, MS is the most common disease affecting the
nervous system of young adults. 1,4 Multiple sclerosis is most commonly
characterized by relapses, or exacerbations, of active disease lasting from 48
hours to several weeks, followed by lengthy periods of improvement, or
remission, where symptoms may diminish or even disappear for periods of
months to years. 1,4,6
Multiple sclerosis is considered to be a primary demyelinating disease
because it attacks the myelin sheaths while sparing the axons. 3 Following the
destruction of the sheath, patchy areas of inflammation are found along the
CNS. Scar tissue and plaques, or 'sclerosed' areas, are then formed where the
myelin sheath previously served to protect and insulate the nerve fibers.
Because of the destruction of the myelin sheath, the conduction of the nervous
impulse is short-circuited, interrupted, blocked, or slowed. 1,2 With the
progression of MS, new plaques form, old plaques expand, and nearby plaques
join to form larger sclerosed areas. 1 Remarkably, it is not rare to find plaques
two to three centimeters wide and several centimeters long. 4 In active plaques,
the sclerosed areas continue to harden and contract, permanently damaging
some nerve fibers running through them. In older plaques, astroglia invade the
central portion of the scars which were formerly occupied by oligodendroglia,
white blood cells, some remains of myelin, and other such remnants from the

3
inflammatory process. 1,3 This is of significance because, without oligodendroglia,
remyelination will not occur.
An estimated 250 000-350 000 Americans 5,7 have been diagnosed with
MS, with approximately 200 new cases reported every week. 2 Most patients are
between the ages of 15 and 50, with a mean age of 30, when the disease first
strikes. 1,5,7 Women are diagnosed two times more often than men and
Caucasians more frequently than Asians or African Americans. 1,2,5,7 The
prevalence of MS in the United States varies from 15 to more than 100 cases
per 100 000 persons of all ages. 1 Interestingly, MS is more prevalent in colder
climates 2 or those places more distant from the equator, such as the Northern
U.S., Canada, and Great Britain .1,7 In contrast, MS is quite uncommon in those
countries near the equator, such as China, Japan, and the Indies. 5 The
incidence of the disease is related to place of residence, especially for the first
15 years of life. 2,5 For instance, migration from a low- to high-risk area during the
childhood or adolescent years is associated with an increase in rate of MS, while
migration from a high- to low-risk area during the formative years is related to a
decrease in the rate of the disease. 1 However, adults who immigrate from
equatorial countries to more northern ones have a lower incidence of MS than
the natives; while adults who immigrate to more equatorial places have a higher
incidence of the disease than natives.
Since MS can affect any part of the CNS, initial symptoms can be quite
variable. 3 The signs and symptoms of MS vary significantly from one
exacerbation to the next, as well as among individuals. 2 Symptoms of this
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disease most commonly appear, remit, and reappear; often involving other
areas, as well as with varying degrees of severity.1 .5 Certain areas of the CNS
are more vulnerable to myelin destruction and subsequent scar formation. Signs
and symptoms of MS are the result of the plaques and sclerosed areas along the
axon which, in effect, block or distort the conduction of the nerve impulse to and
from the various centers in the brain.1 Early symptoms of MS most often involve
sensory rather than motor deficits. For instance, it is not uncommon for an
individual to initially experience paresthesias in one or more limbs; bowel,
bladder, and sexual dysfunction; diplopia; blurred vision or other such problems
associated with optic neuritis; vision loss; loss of proprioception; and vertigo .1-8
Of the above, sensory involvement of limbs, gait and balance disturbances,
visual loss, and diplopia are most frequently reported as initial symptoms.
Balance can be adversely affected by any of the early signs and symptoms
associated with MS. 8
Late symptoms may include dyscoordination; muscle cramps, weakness,
and fatigue; spasms; slurred speech; paresis; paralysis; pain; depression or
other mood changes; spasticity; loss of balance; ataxia; intolerance to heat; and
intention tremor. 1-8 Of these, balance abnormalities were found approximately
80% of the time throughout the course of the disease. 8 Impaired sensation,
fatigue, paraparesis, visual loss, weakness and dyscoordination of limbs, and
diplopia were most often reported as symptoms found throughout the course of
MS. These symptoms are also very much related to balance. Some patients

5
experience memory loss and impairment, decreased mentation, depression, and
mood sWings. 2,4
Throughout the course of the disease, it is not unusual to experience
multiple symptoms simultaneously; however, with optic neuritis, people
commonly present with this singular abnormality.5 Symptoms of MS are most
often rapid in onset, with variable intensity. Usually early signs and symptoms
completely remit after six to eight weeks. The persons' ability to perform
functions of daily life fluctuate from day to day and from attack to attack, and are
further influenced by fatigue, temperature, type of MS, and other unknown
factors. 3 An estimated two-thirds of persons with MS are ambulatory throughout
the course of the disease, but many require assistive devices to do so? It is not
possible to predict if or when an attack of symptoms will occur; however,
exacerbations may be the result of certain external factors, such as infections,
stress, pregnancy, trauma, emotional distress, exposure to cold, surgical
procedures, and fatigue and over-exertion. 1,3,6 Nonetheless, for the majority of
relapses, no precipitating factor can be found. 3
Multiple sclerosis ranges from very mild to intermittent to very severe and
rapidly progressive forms.2 Since the course of the disease is very unpredictable
with an astonishing amount of variability between patients, this disease is
classified into several categories based on the severity and degree of neurologic
impairment. 7
Approximately 20% to 35% of patients with MS experience mild symptoms
that either remit suddenly or over time or are never even detected. This category
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in which people experience no or very few attacks with no recurrence afterward
is known as benign MS.1,2,S,8 With benign MS, onset of symptoms usually include
optic neuritis and paresthesias of limbs and trunk. Remission is complete, and
severe or permanent disability does not develop.3
The majority of patients with MS-some 50% to 65%-have unpredictable
attacks followed by bouts of remission lasting months or even years. 1,2,S This
category of MS, which is characterized by numerous exacerbations and
remissions of signs and symptoms, is known as the relapsing-remitting type. It is
not uncommon for some of these patients to have only limited disability even 20
or more years after the diagnosis.s Quite often, after the active period of relapse
and remission-lasting approximately five years-the pattern of MS changes,
resulting in no more acute attacks and more spontaneous recoveries. 3
A third category of MS is known as relapsing or chronic/progressive,
whereby approximately 25% of patients develop significant neurologic
disability.2,s Some recovery following attacks is observed,8 but approximately 15
years after the diagnosis, most will require the use of an assistive device for
gait. s
The fourth and final type of MS is known as the primary progressive
type. 1,s Approximately 10% of patients fall into this category and experience a
progressive course from the onset of the disease, with the absence of
exacerbations and remissions. 3,s Interestingly, this group is comprised mainly of
older males and usually includes some spinal cord involvement. s
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In general, patients with MS have a better prognosis if the disease course
begins earlier in age, if symptoms are primarily sensory versus motor, and if the
person is of the female gender. 5 Ultimately, approximately 50% of persons with
MS of the relapsing-remitting, chronic/progressive, and primary progressive
types will experience a progressive course. 7 Rao 4 states that the course of the
disease is typically one that gradually worsens over an almost normal life span.
The life expectancy of people with MS is only slightly less than in the general
population7-about 75% of normal. 1 Even though the life span is comparable to
that of the general population, the quality of life may be quite different than that
normally found. For instance, many individuals with MS are unable to walk
effectively or to perform other functions of daily life secondary to the common
symptoms of weakness, spasticity, dyscoordination, altered balance, and
disturbances of the visual and somatosensory systems. 8 Nonetheless, there are
many adaptive devices and techniques in addition to environmental modifications
that make activities of daily living easier and safer for the person with MS.
What exactly causes MS is unknown,1-4.6-8 although studies have
suggested that a combination of inherited and environmental factors may be to
blame. 3.6.7 There does appear to be a genetic predisposition in that the rate of
MS increases slightly when there is a close relative with the diagnosis.1.7 More
specifically, research suggests that instead of one or two cases of MS per 1000
in the US, in families where MS is found, the risk increases to three per 100. 7
This is a higher risk, but not a major factor when determining the cause of MS.3
There is no evidence that MS is directly inherited in the general population2;
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rather, evidence suggests that persons who develop MS inherit a predisposition
to the disease, perhaps with a weakness to an offending agent in the
environment. 1 Studies with identical twins-with identical susceptibility
genes-show that the second twin develops MS only half of the time. Therefore,
even with evidence suggesting a genetic predisposition, other research shows
environmental factors are just as important. 4
Studies have suggested that a person's genes are related to the
susceptibility to and character of MS.1 Research has found that there is an
increase in the chromosome crossover rate in persons with MS. This is an
inherited disorder and has that potential to create a disease process.
Moreover, evidence has suggested that exposure, especially in the
childhood years, to an offending agent, such as a virus, may cause the MS
disease process.3,7 Studies have suggested that MS probably begins during
childhood and adolescence with signs and symptoms not appearing for a period
of years.1 If such evidence were true, then re-exposure to certain viruses could
trigger a relapse . Viral theories are supported by the latitude effect and
migration studies;1 ,3 twin, family, and sib-pair studies; and the association
between many attacks of MS symptoms and upper respiratory infections.1
Another similar theory is that MS is caused by an infectious agent
resulting in an allergic response. 6 Studies have suggested that MS may be an
autoimmune disease, whereby the body's immune system (white blood cells)
fails to recognize "self' tissue and destroys it as though it were "foreign ."1,3,4,7
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Diagnosis of MS is based on the patient's clinical history, the neurological
exam showing signs of progressive neurological dysfunction and the lack of a
differential diagnosis. 7 Multiple sclerosis is usually difficult to diagnose because
many of the early signs and symptoms come and go or are even indicative of
another disease. There is no single neurological or laboratory test that is
definitive of MS.2 ,6 To make a conclusive MS diagnosis, however, two factors
must be met: 1) evidence of several areas of plaque formation in different areas
of the CNS and 2) at least two separate exacerbations of the disease. 1,2,5
Diagnosis of MS is made more certain with the help of neurological tests such as
nuclear magnetic resonance imaging (MRI), computed tomography (CT) scan,
cerebrospinal fluid (CSF) analysis, evoked potentials, and
electroencephalography (EEG).1 ,4,6,7 While no definitive test for MS exists, MRI is
the most sensitive test-ten times more sensitive than CT-for detecting MS
plaques4 and can locate lesions as the disease progresses. 4 ,6 Approximately
95% of patients with MS demonstrate multiple sites of plaque formation in the
CNS. 5,6 Evoked potentials detect abnormalities in the conduction of nervous
impulses.1,4 Lumbar puncture and CSF analysis, while not specific for MS, do
show strong evidence of the disease. 4,5
There is no prevention or cure for MS at this time; 1-9 however, much can
be done to aid people in functioning at their optimal level. Some treatment may
even result in reducing the frequency and severity of atlacks. 2,5,7,9 For instance,
several new medications are used to decrease muscle spasms and stiffness ;
reduce fatigue; control bladder symptoms, sexual dysfunction, and pain; improve
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coordination; and control depression and other mood changes. 1 Other
medications, such as adrenal hormones and corticosteroids, help shorten
relapses,3.7 while interferon beta 1a and 1b are used to modify disease activity by
decreasing frequency and severity of relapses .s-7 Baclofen and dantrolene are
used to reduce spasticity that is often found in patients with long-standing MS.6
Supportive measures for individuals with MS may include physical and
occupational therapy to maintain and increase strength and range of motion of
involved musculature, in addition to help maintain mobility.3 Exercise programs,
diet, adequate rest, and counseling to combat depression are other measures
recommended for persons with MS. 2 •6
In regard to exercise, it is most effective following an acute attack, during
the remitting stage. Vigorous exercise is not recommended during acute
relapses or with rapidly and progressing forms of MS.8 The effects of exercise
are dependent on the damage done to the eNS; fatigability; and the severity of
spasticity, uncoordinated movements, and weakness. The general goals of
exercise include increasing strength, range of motion, endurance, and
coordination . When balance deficits are observed, specific balance exercises
should be chosen according to the specific needs of the patient. 8 For instance, a
patient who is having difficulties with sit to stand transfers should practice
specifically on that task. Other persons whose balance is less affected may
benefit more from challenged balance activities , such as tandem walking, step
up and over, side stepping, braiding, or controlling movements on a tilt board.
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Collectively, there are approximately 40 treatments for MS available.
Unfortunately, most have little or no effect on the disease, undoubtedly because
the cause of MS is still unknown.1 Other less popular treatments include
immunosuppression, transfer factor, antiviral treatment, gluten-free diet,
unsaturated fatty acid diet, rest/exercise, and dorsal column stimulation.3
Balance
Balance, or postural control, is defined as "the ability to maintain or move
within a weight bearing posture without falling."10 There are three components of
balance: static steadiness, symmetry, and dynamic stability. Static stability is
defined as the ability to sustain an upright posture with minimal sway. Symmetry
is defined as having equal weight distributed between the weight bearing
components. 11 .12 Dynamic stability describes the ability to move within a given
posture without

a loss of balance (LOB).10

It is important to understand that

static and dynamic balance are greatly affected by vestibular, visual, and
somatosensory feedback.11-15 These postural components provide the CNS with
afferent (sensory) input, which can then be followed by the appropriate and
effective efferent (motor) response from the CNS. 16 When these systems are
functioning adequately, an individual is able to maintain the center of gravity
within the base of support with minimal extraneous movement, or sway.
However, if one or more of these systems is compromised, which is often the
case in persons with MS, the CNS adjusts by utilizing inputs from the remaining
systems to maintain postural control. 13 In other words, the CNS relies more
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heavily on the feedback from the remaining systems in order to reduce sway, a
measure of postural control, to avoid a LOB.
Visual Input
The optic nerves comprise part of the CNS and are, therefore, susceptible
to demyelination and subsequent plaque formation. In approximately 15% of
persons with MS, optic neuritis was reported as the initial symptom. 3
Fortunately, vision usually improves within one week. It is also common for
people with MS to experience diplopia, blurring of vision, and loss of vision. 1- 9
Persons with MS reported experiencing visual loss or diplopia as an initial
symptom 30% of the time. Throughout the course of the disease, however,
individuals reported experiencing some type of visual loss or diplopia 98% of the
time. 8 Therefore, one can conclude that visual abnormalities, at least sometime
throughout the disease process, are a problem for persons with MS. Since
visual input is an important component in postural stability, one can then assume
that balance may be significantly compromised unless the CNS can rely more
heavily on the feedback from the other two components.
Vestibular Input
The vestibular system is responsible for detecting changes in the linear
acceleration and deceleration forces acting on the head, as well as angular
velocity effects on the head .11 •17 This system also provides feedback necessary
to reference the position of the head in response to gravity. Moreover, the
vestibular system provides the output necessary for two important reflexes, the
vestibulospinal reflex (VSR) and the vestibulo-ocular reflex (VOR). The VSR
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allows for head and postural control in order to prevent falls. The VOR controls
the eye movements and allows for clear vision during head movements. 17
Vestibular input is also responsible for the righting reflexes which, in turn, are
responsible for allowing the body to maintain balance when confronted by
sudden movements. The vestibular system is commonly affected by MS, with
most persons experiencing episodes of vertigo and dizziness. Vestibular input
becomes increasingly important in providing feedback to the eNS when the
visual or somatosensory systems are compromised.
Somatosensory Input
The third component important for postural stability is the somatosensory
system or proprioceptive component. This input is preferred by most healthy
adults for maintaining an upright position. 13 Proprioceptive input from the
mechanoreceptors of the foot and ankle provide input to the eNS to promote
postural stability and reduce sway.11,18 Patients with MS reported experiencing
sensory abnormalities of the extremities as an initial symptom of the disease
approximately 35% of the time, compared to approximately 70% of the time
during the course of the disease. 8 It appears that impaired sensation is quite
frequently reported as an early and late symptom of MS.1 This being the case,
one can conclude that the somatosensory or proprioceptive input to the eNS is
diminished in persons with MS. Unless the eNS succeeds in integrating input
from the other two systems, balance will likely be greatly affected.
It has been reported that balance disturbances are noted 20% of the time
as initial symptoms of MS. Abnormalities in balance are reported to occur 80%
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of the time throughout the course of the MS disease. 8 Studies have found that
instability and increased body sway are associated with vestibular abnormalities,
visual problems, loss of vibration sense and lower limb tendon reflexes, and
multi-sensory deficiencies in healthy adults. 18-21
Recent studies of patients having suffered a cerebrovascular accident
(CVA) with resulting hemiplegia utilized force platform systems for assessing and
retraining postural controI. 10,14,22-24 These systems provide visual and/or aud itory
feedback to the patients regarding the position of the center of gravity (COG) .
The NeuroCom Balance Master® (NBM®) is one such piece of equipment that
provides the patient with visual feedback of the location of the COG in relation to
the limits of stability (LOS).14,25 The NBM® consists of a dual-force platform
connected to a microprocessor and uses an estimate of the person's COG
projected as a reference point on a computer screen. 25 In addition, numerous
training protocols on the NBM® may be utilized to optimize three components of
postural stability. These measures of postural control- static steadiness,
symmetry, and dynamic stability-are used most often during the balance
assessment using the force platform system. 10,26 Lee et al 23 state that
biofeedback, such as that provided by the NBM®, is a most effective method in
improving postural instability immediately in hemiplegic subjects as well as for
those individuals who can use the visual or auditory feedback. Other studies
found that improvements were noticed very quickly and with very little
treatment. 27
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Force platform measures of postural sway have been reported to be valid
and reliable when using the center of force versus the center of pressure
measures. 10,26 Liston et al 24 suggested that for CVA patients, complex tests of
balance proved to be more reliable than static steadiness or symmetry tests.
Dynamic stability measures proved to be more valid measures of functional
balance performance than static steadiness measures. 10,24 However, Liston and
colleagues 24 found that only the LOS test among the dynamic stability measures
was highly reliable. Liston and colleagues24 recognize that other studies have
argued that the majority of the variables tested with the NBM® were found to be
valid measures of balance. 24
Force platform studies with hemiparetics have shown varied results;
however, for the most part, some improvements in postural stability have been
observed. 1o,11,22 Studies have suggested that symmetry and dynamic stability
measures may provide more accurate information of patient progress. 10,27 These
two measures show consistent improvement with use of visual biofeedback
using force plate systems. 10,27 A study by Shumway-Cook and associates12
indicated that hemiplegic subjects improved in measures of static stability when
trained with a force platform balance system. Studies showed improvements in
stance, weight transference, and in tolerance of imposed forces. 11 ,27 While
Liston and colleagues 24 found that standing balance training in hemiparetics
improved postural control, that improvement did not carry over to improve
locomotor function. These studies suggest that performance is task specific. A
study by Panzer et al29 concluded that balance retraining of hemiplegics using
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the NBM® improved midline positioning, standing mobility, and transfers. Again,
these improvements did not translate to improvements in functional mobility,
such as gait. In contrast, a case study of two patients with hemiplegia,
conducted by Sackley et al,27 suggested that training effects from visual
biofeedback did translate to improved functional skills, thereby increasing
activities of daily living (ADL) scores.
When designing a treatment program utilizing the NBM® to optimize
effectiveness, one should identify and focus on the particular needs of the
patient. 13 It is also important to design a balance program that readily translates
to a new learning situation. 13 A study by Maurer and colleagues 13 concluded that
a training schedule of 20 minutes three times per week over a period of three
weeks was just as effective as a more concentrated schedule. Further, Nichols 10
found that programs which incorporated various training activities have provided
consistent changes in patients' level of function, including transfers, gait, home
mobility, endurance, functions of daily life, and gross motor function.
Purpose of Study
Recently, there has been a growing acceptance for the utilization of a
force platform biofeedback system for evaluation and treatment of various
neurological and orthopedic diagnoses. 23 ,26,28 At this time, there is no research
available concerning balance assessments of and retraining for patients with MS
using a platform biofeedback system. Therefore, the purpose of this study is to
determine if significant changes occur in static steadiness, symmetry, and
dynamic stability following a balance retraining program on the NBM®.
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Research Questions
Thisresearch project will answer the following questions: 1) Is there a
significant difference in measures of static steadiness between the control and
treatment groups utilizing the NBM® for balance retraining? 2) Is there a
significant difference in measures of symmetry between the control and
treatment groups? 3) Is there a significant difference in measures of dynamic
stability between groups with utilization of the NBM®for balance retraining?
It is hypothesized that there will be a significant difference between the
control and treatment groups based on a comparison of the initial to the final
balance assessment. The alternate hypothesis states that the treatment group
will demonstrate improvements in static steadiness, symmetry, and dynamic
stability as compared to the control group who should demonstrate either no
change in balance or perform slightly worse secondary to the general
progressive course of the disease.
Because balance is an integral part of a physical evaluation for a
multitude of patient diagnoses, including MS, the significance of conducting this
study involved the utilization of the NBM®to assess and retrain patients with MS
in an objective and systematic manner. Upon completion of this study, the
results can be useful to a clinician eager to use a force platform system with
biofeedback to improve balance. As a physical therapist, it is important to
examine possible therapeutic treatment modalities that may prove successful in
treating various symptoms of MS and be able to apply the tool to other patients
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as well. Finally, this study can be used as a basis for future research involving a
larger sample size and/or a longer period of time for balance retraining .

CHAPTER II
METHODOLOGY
An Institutional Review Board form describing the purpose and format for
this study was completed by the researchers and approved by Altru Health
Systems and the University of North Dakota (see Appendix A). A meeting
between the researchers and the neurologist involved in this study was held to
discuss selection of subjects and inclusion criteria for participation.
Subjects
A sample of convenience was used from a population pool of MS patients
under the care and supervision of a neurologist. Subjects were contacted by
telephone and scheduled for an initial assessment. Inclusion criteria for
participation in this study consisted of: 1) a diagnosis of MS, 2) a score in the
3.0 to 6.0 range on the Neurological Assessment Kurtzke Functional SystemsEDSS (see Appendix B), 3) an absence of secondary diagnoses that may
interfere with this study, 4) no prior experience using the NBM®, and 5)
permission from the neurologist associated with this study. Subjects were
excluded if: 1) one or more of the above criteria were not met or 2) unable to
understand and follow instructions.
Two groups of five subjects (mean age = 50.9 ± 4 .5 years) were selected
based upon ability to participate in this study. Those subjects who either lived in
19
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rural locations or were unable to participate in the retraining program due to work
or other time conflicts were assigned to the control group. The treatment group
was composed of those subjects who expressed a desire to participate and were
able to commit their time to the four-week retraining program. The control group
consisted of five subjects (4 females, 1 male) who performed an initial and final
balance assessment on the NBM® only. The subjects in the control group
received no balance retraining between testing trials. The treatment group
consisted of five subjects (2 females, 3 males) who participated in an initial and
final balance assessment and a balance retraining program three days per week
for four weeks. The initial and final balance assessments for both groups and
the retraining program for the subjects in the treatment group were performed
using the NBM®. Refer to Table 1 for descriptive data of subjects.
Questionnaire and Initial Evaluation
Upon arrival at the research site, subjects were given a consent form and
a questionnaire (see Appendices C and D, respectively). The questionnaire was
given to all ten subjects before beginning the initial assessment on the NBM®.
Questions were related to subjective ratings of balance difficulties, number of
falls in the last month and year, previous hospitalizations, health problems,
medications, sensation, vision, exercise, work schedule, and use of an assistive
device. A general screening was performed on each subject prior to beginning
the assessment on the NBM® and consisted of manual muscle, range of motion,
reflex, and sensation testing (see Appendix E).

Table 1.-Descriptives of Subjects

Subject

Age

Sex

Group

Years

Side
Involved

Assistive
Devices Used

Balance
Difficulties

# Times Fallen
Height
Month

Year

1

49

F

C

11

L

cane

mild

0

0

64

2

53

F

C

7

L

no

mild

0

0

64

3

52

F

Rx

13

R

cane

moderate

5

50-60

68

4

58

F

C

6

R

cane

mild

0

2

62

5

53

F

Rx

6

L

cane

severe

4-5

20-25

65

6

52

M

Rx

5

L

no

moderate

0

1-2

73

7

48

M

Rx

5

R

no

moderate

0

0

73

8

42

M

Rx

14

L

cane

moderate

3-4

40-50

69

9

47

M

C

9

R

cane

mild

2

20-25

73

10

55

F

C

28

Equal

cane

moderate

5-10

50-60

63

N
t-'

control mean age = 52.4 years
treatment mean age = 49.4 years

22
Instrumentation
The NBM® (NeuroCom® International, Inc, 9570 SE Lawnfield Road,
Clackamas, OR 97015-9611, Telephone (800) 767-6744) used in this study is
composed of two adjacent force platforms (each approximately 155 cm long)
resting on four load cells which transfer information from the platform system to a
connecting computer. 14,30 The computer monitor is located at the superior end of
the platform and is positioned at eye level to the subject with a cursor
representing the center of gravity (COG) as a reference point in relation to the
theoretical limits of stability (LOS). The balance master system offers an
objective measure of balance and balance-related activities for the patient and
clinician by giving continuous visual feedback and statistical information
regarding performance on each test and retraining measure. 14 The machine is
sensitive to all types of individuals and accommodates ambulatory and nonambulatory populations. Objective and quantitative data are available on
computerized printouts depicted as graphs, numerical charts, and actual picture
representations of the assessment with tracing of the COG movement.
Immediate results can be obtained to monitor static steadiness, symmetry, and
dynamic stability. Visual feedback is given during retraining with the COG
represented as a cursor and movements of the COG depicted as yellow lines
indicating linear displacement.
Although there has been a wide acceptance in using the NBM® in the last
several years, only recently have reliability and validity issues been addressed.
Liston and colleagues 24 concluded that measurements of dynamic stability in
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subjects with hemiplegia were more reliable and valid than those for static
steadiness and symmetry. Speculation must be used when interpreting data
from this study, in particular, because a generalization cannot be made from one
medical diagnosis to another. Therefore, further research is needed to produce
normative data to establish reliability and validity values for different populations
using the NBM®.
Hamman et al 14 concluded that a high "learning curve" exists when using
the NBM® because significant changes were seen in normal, healthy subjects
over repeated retraining sessions. This learning effect was found to increase
during the first few training session before gradually reaching a plateau . This
indicates that a "learning curve" developed within a specific time period. This
means that once a threshold has been reached, the body must use higher
cortical processing to achieve greater levels of learning. Due to the small
sample size in the study by Hamman et al,14 further research is needed to
establish normative data for "learning curves" in neurological populations.
Because MS is a complex disease with a multitude of secondary complications
associated with the degree of eNS involvement, difficulty arises in comparing
MS subjects to norms of different populations.
Procedure
An introduction to the force platform system for each subject included a
general description of the apparatus, how performance is measured, balance
strategies utilized to maintain balance, subject expectations , and a warm-up
session . Subject data consisting of an identification number, date of birth, and
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height were entered into each subject file. Before the initial balance assessment
began, each subject was instructed in proper foot placement on the forceplates .
Proper foot placement on the force platform system consisted of aligning
the lateral border of each foot parallel to a transverse line and alignment of the
medial malleolus perpendicular to this. The feet were symmetrical on the force
platform with the exception of allowing the subject to splay the forefoot to a
comfortable position . This same foot placement was utilized during the testing
procedures and retraining exercises which required subjects to be in an erect,
standing position. Subjects were instructed to wear the same shoes worn during
the initial and final balance assessments and during balance retraining .
Prior to testing, each subject performed a warm-up on the NBM® which
consisted of weight shifting to 25%, 50%, 75%, and 100% LOS. The subject's
COG was represented as a cursor located in the center of the screen. Each
subject was instructed to lean forward, backward, and side to side; to keep the
knees straight; and to pivot around the ankle joints to maximize the ankle
strategy. Subjects were placed in level one, two, or three depending on the LOS
excursion achieved. The warm-up was also used to orient the subject to the
apparatus and to assist the subject in gaining cursor control. Once subjects
became comfortable with the force platform system, the balance assessment
began.
Assessment
An initial balance assessment was performed three days prior to week
one of the study, and a final assessment was performed one day after week four.
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Due to the high learning curve associated with the NB~, a warm-up and two
initial and final assessments were completed; however, only the data from the
second assessment were used for data analysis.
Adequate rest periods were given between assessments as well as during
testing or retraining when needed . Specific instructions describing each test
were given, per NBM® manual, to all subjects prior to each assessment test. In
this manner, the following balance tests were performed by each group during
the initial and final balance assessments: bilateral stance, rhythmic weight
shifting, limits of stability, walk, sit to stand, weight bearing symmetry, and step
up/over.
After completion of the initial assessments, the control group (n

=5) was

scheduled for a final assessment to be performed four weeks from that date.
After data from the initial assessment were analyzed, subjects from the control
group received a written explanation via mail, while the subjects from the
treatment group received a verbal explanation at their next scheduled retraining
session regarding their balance performance on the NBM®.
Definitions of the parameters for each assessment test are provided in the
glossary. Refer to the glossary in Appendix F. Please refer to the NBM®
Operator's Manual for more detailed information. 3D

Static Steadiness Test #1
The bilateral stance test involved static standing in a predetermined area
on the force plates for measurement of mean COG sway velocity with eyes
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open or eyes closed. A firm surface was utilized for subjects whose LOS was
less than 50%, while a foam surface was used for subjects exceeding 50% of
their LOS. Standing body sway was recorded for 10 seconds, times three trials.
The measured parameter for this test was mean COG sway velocity.
Symmetry Test #1
The weight bearing/squat test measured weight distribution between the
right and left lower extremities at 0 0 and 30 0 of knee flexion. Subjects were
required to assume a static position on the specified platform area and the force
was recorded. A goniometer was used to accurately measure knee flexion
during the squat. The recorded data consisted of percentages that represented
the weight borne on each leg to show symmetry of the lower extremities for two
trials, one at 0 0 and one at 30 0 •
Dynamic Stability Test #1
The LOS test involved eight targets arranged in a circular fashion around
a central starting box. Depending on the subjects' LOS in the warm-up, the
circular arrangement was adjusted to 50% or 75% of the measured limits. Each
subject's COG was represented as a cursor positioned in the middle of the
computer screen. Subjects were instructed to lean into the direction of the
highlighted target as quickly as possible and briefly maintain a static cursor
position on the target before returning to midline. Each subsequent target was
highlighted in a circular fashion until all eight targets were reached. Parameters
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measured for this test were: reaction time, sway velocity, directional control,
endpoint excursion, and maximum excursion .
Dynamic Test #2
The rhythmic weight shifting test consisted of two tests: weight shift
forward/backward and left/right. Two end-lines represented the distance each
subject had to move during the weight shifting test. The subject was required to
follow a small moving box which automatically moved between the two end-lines.
Auditory and visual feedback was provided by the NBM® to assist the subject in
moving the cursor between the points at a three-second transition rate for six
excursions. Measured parameters included intentional or on-axis sway velocity
and directional control.
Dynamic Test #3
The walk test measured several aspects of gait as the subject ambulated
from one end of the forceplate to the other as quickly as possible. When the
monitor displayed the word "GO," the subject walked to the end of the forceplate
and held steady. This test is performed three times. Measured parameters were
step width, step length, speed, and endpoint sway velocity.
Dynamic Test #4
The sit-to-stand test quantified several components of movement as the
subject transferred from a seated position on a 20-inch wooden box to a
standing position. When the word "GO" appeared on the computer screen, the
subject rose as quickly as possible from a seated position without use of the
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upper extremities and held steady for 20 seconds. This test was performed
three times. Measured parameters were weight transfer time, rising index,
COG sway velocity, and right/left weight symmetry.
Dynamic Test #5

The step up/over test required the subject to step up onto a four- or eightinch high curb (depending on each subject's performance during prior tests) with
one leg, to swing the other foot over the curb and onto the floor, and step down
with the curb foot. When the word "GO" appeared on the screen, the subject
stepped up and over the box as quickly as possible and held steady for five
seconds. The measured parameters were lift-up index, movement time, and
impact index. The test consisted of six trials, three leading with the left foot and

three leading with the right foot.
Training
The treatment group (n = 5) was seen three times per week for four weeks
for balance retraining exercises . Subjects in both groups were instructed to
maintain their daily activities and to avoid participating in any new extracurricular
activities (in addition to this study), as this could skew research findings. All
subjects were instructed to report any exacerbation of symptoms during this fourweek period .
The balance retraining program for each subject in the treatment group
was individualized according to performance and subject progression . Balance
retraining exercises included seated circles on a firm 20-inch wooden box,
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progressing to a 16-inch firm wooden box with a 6-inch foam cushion, and finally
progressing to a medium-sized therapeutic ball. The progression of closed chain
exercises consisted of forward/backward, left/right, and figure-of-8 pattern weight
shifting with progression from a firm to foam surface and finally a tilt board.
Mobility training involved right step, left step, and alternate stepping which was
progressed by increasing the step length and decreasing the amount of time
each subject was allowed during stepping. The progression of gait was from a
wide base of support, to a medium base, to heel-toe tandem walking, as well as
decreasing the time available to get from one end of the platform to the other.
Stepping activities were progressed from step up, to step up/over, as well as
step up/over and back, and increasing the height of the box from 4 inches to 8
inches to 16 inches. Progression to a more difficult level was guided by each
subject's performance in the exercise retraining program.
All subjects in the treatment group completed the retraining sessions three
days per week. Due to scheduling conflicts, two subjects needed to reschedule
their appointments; however, all subjects completed three sessions per week
with no absences.
Data Analysis
The data from the initial and final balance assessments for both the
treatment and control groups were entered into the SPSSTM software system.
With this program, the mean, standard deviation, standard error of the mean, the
minimum and maximum scores, t-statistic, degrees of freedom, significance,
mean difference, and standard error difference were calculated. These
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parameters were used to detect significant changes in components of static
steadiness, symmetry, and dynamic stability between groups from the initial to
the final balance assessments on the NBM®.
Reporting Results
Upon completion of this study, a summary regarding the results will be
completed and sent to each subject and to Altru Health Care Systems. A copy
of this independent study will be given to the neurologist involved in this research
project, the preceptor, and the University of North Dakota. This study was
completed to fulfill the requirements for the University of North Dakota School of
Medicine and Health Sciences Physical Therapy Program.

CHAPTER III
RESULTS
An independent measures t-test was used to determine if there were
significant changes found between groups in measures of static steadiness,
symmetry, and dynamic stability. Two of the 43 components of balance showed
significant changes between groups.
Subject Profile
Ten subjects (6 females, 4 males) participated in this study. No subjects
were excluded and all data were used. Five subjects (4 females, 1 male) with an
,

age range of 47 to 58 and a mean age of 52.4 years participated in the control
group. All testing for this study involved balance assessments on the NBM®.
Subjects in the control group were seen twice over a four-week period, once for
an initial balance assessment at week one and once for a final balance
assessment at week four. Five subjects (2 females, 3 males) with an age range
of 42 to 53 and a mean age of 49.4 years participated in the treatment group.
Subjects in the treatment group were seen by the researchers for an initial
balance assessment at week one, balance retraining three times per week for
four weeks, and a final balance assessment after week four.
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Data Analysis
The independent variables (IV) in this study consisted of the treatment
and the control groups. The dependent variables (DV) were changes between
the initial and final balance assessments measured as "gain/loss" scores. The
"gain/loss" score was defined as the mean change in performance between the
initial and final balance assessments.
Initially, data were examined using analysis of co-variance (ANCOVA).
Fifty of the 57 statistical tests did not meet the assumptions underlying the
ANCOVA; therefore, all analyses utilized the independent measures t-test. This
test was used to determine if there was a significant difference in static
steadiness, symmetry, and dynamic stability between the treatment and control
groups. Statistical analysis was two-tailed and the level of significance was set
at (p < 0.05) for all tests.
Static steadiness: Is there a significant difference in measures of static
steadiness between the control and treatment groups? Static steadiness

was analyzed via five measures as listed in Table 2. Assumptions of the t-test
were met in one of the five components. No significant difference was found
between the treatment and control groups for any measure of static steadiness.
Symmetry: Is there a significant difference in measures of symmetry
between the control and treatment groups? Symmetry was analyzed via

eleven measures as listed in Table 3. Assumptions of the t-test were met in all

Table 2.-Components of the Tests for Static Steadiness

t
COG Sway Velocity*

df

Significance
(2-tailed)

Mean
Difference

Standard Error
Difference

-.572

8

.583

-.4400

.7692

End Sway*

.144

8

.889

. .1200

.8362

Mean Center of Gravity Sway Velocity*
(eyes closed)

.292

4.174

.784

4.000E-02

.1371

Mean Center of Gravity Sway Velocity*
(eyes open)

1.723

8

.123

.1400

8.124E-02

Mean Center of Gravity Sway Velocity
jcomposi!~ ._ .____._ ._ _ .

.566

8

.587

4.000E-02

7.071E-02

I

J
I

w
w

* Indicates data were not normally distributed.

Table 3.-Components of the Tests for Symmetry

t

df

Significance
(2-tailed)

Impact Body Weight (left)

-.201

8

.845

-1.2000

5.9582

Impact Body Weight (right)

2.088

8

.070

9.0000

4.3105

Impact Index Difference

1.091

8

.307

18.8000

17.2319

Lift-up Index Difference*

2.069

8

.072

16.4000

7.9246

Left/Right Weight Symmetry

-.924

8

.382

-7.0000

7.5750

Lift-up Index Body Weight (left)

-.936

8

.377

-1.8000

1.9235

Lift-up Index Body Weight (right)

1.976

8

.084

4.4000

2.2271

.209

8

.840

.2000

.9592

Weight Bearing (left) (0°)

1.373

8

.207

7.2000

5.2440

Weight Bearing (left) (30°)

.593

8

.570

4.6000

7.7627

Weight Bearing (left) (60°)

-1.189

6

.279

-9.2500

7.7822

Weight Bearing (right) (0°)

-1.373

8

.207

-7.2000

5.2440

Weight Bearing (right) (30°)

-.593

8

.570

-4.6000

7.7627

Weight Bearing (right) (60°)

1.189

6

.279

9.2500

7.7822

Rising Index

* Indicates data were not normally distributed.

Mean
Difference

Standard Error
Difference

I

I

I

I

I

I

I
!

I

I
I
I
I

I

I

w

+=>
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cases. No significant difference was found between the treatment and control
groups for any measure of symmetry.
Dynamic stability: Is there a significant difference in measures of dynamic
stability between the control and treatment groups? Dynamic stability was
analyzed via 37 measures as listed in Table 4. The assumption for normal
distribution of the independent variable was not met for 6 of the 37 components,
and the results were analyzed only with descriptive measures. Thirty-one
components met the assumptions of the independent measures t-test. A
significant difference, t(8)

=.042, P < .05, two-tailed was found between groups

for the component of endpoint excursion forward. A significant difference, t(8)
= .029, P < .05, two-tailed was also noted for the component of maximum

excursion endpoint forward . Endpoint excursion forward was greatest for
the treatment group, with a mean of 11.4% LOS. The mean for the control group
was -5.6% LOS which resulted in a mean difference of 5.8% LOS between the
groups. Maximum excursion endpoint forward was also greatest for the
treatment group with a mean of 4% LOS. The mean for the control group mean
was -9.4% LOS which resulted in a mean difference of -5.4% LOS between
groups.

Table 4.-Components of the Tests for Dynamic Stability

t

df

Significance
(2-tailed)

Mean
Difference

Standard Error
Difference

1.100

8

.303

6.6000

5.9983

.294

8

.777

4.0000

13.6242

1.979

8

.083

9.4000

4.7497

Directional Control (back)*

.696

8

.506

9.2000

13.2212

Directional Control (composite)

.323

8

.755

1.6000

4.9598

-1.485

8

.176

-11.2000

7.5432

Directional Control (Ieft)*

-.686

8

.512

-5.8000

8.4581

Directional Control (right)

2.666

4.285

.052

14.8000

5.5516

Endpoint Excursion (back)

-.513

8

.622

-6.4000

12.4643

Endoint Excursion (composite)

-.921

8

.384

-5.0000

5.4295

Endpoint Excursion (forwardt

-2.423

8

.042

-17.0000

7.0157

Endpoint Excursion (Ieft)*

.369

8

.722

5.0000

13.5617

Endpoint Excursion (right)

-.072

8

.945

-.8000

11.1553

Movement Velocity (forward)

-1.286

8

.234

-.8800

.6844

Movement Velocity (back)

-2.068

8

.072

-1.0000

.4835

Movement Velocity (composite)

-1.706

8

.126

-.6600

.3868

Directional Control (composite)*
Directional Control (forward/backward)
Directional Control (left/right)

Directional Control (forward)

w

C'I

Table 4.--Components of the Tests for Dynamic Stability (Cant.)

df

t

Significance
(2-tailed)

Mean
Difference

Standard Error
Difference

-1.557

8

.158

-.8000

.5138

Movement Velocity (difference)

.427

8

.680

.3400

.7954

Movement Time (difference)

.525

8

.614

2.6000

4.9497

Movement Time (left leg)

1.062

8

.319

.1240

.1168

Movement Time (right leg)

-.151

8

.884

-3.80E-02

.2519

Maximum Excursion (back)

.044

8

.966

.6000

13.5314

5.644

.487

-2.4000

3.2249

-2.645

8

.029

-13.4000

5.0656

Maximum Excursion (Ieft)*

.028

8

.978

.2000

7.1764

Maximum Excursion (right)

.346

8

.738

2.4000

6.9397

On-axis Velocity (composite)

-.266

8

.797

-.1200

.4508

On-axis Velocity (forward/backward)

-.727

8

.488

-.3400

.4680

On-axis Velocity (Ieftlright)*

.303

8

.770

.1600

.5278

Reaction Time (backward)

-.191

8

.853

-5.00e-02

.2611

Reaction Time (composite)

1.284

8

.235

.1120

.174

8

.866

3.80E-02

Movement Velocity (left)

Maximum Excursion (composite)
Maximum Excursion (forwardt

Reaction Time (forward)

-.744

8.726E-02
.2185

W
'-l

Table 4.--Components of the Tests for Dynamic Stability (Cant.)
Reaction Time (left)

1.339

8

t
Reaction Time (right)

df

.217

.2240

Significance
(2-tailed)

Mean
Difference

.1673
Standard Error
Difference

.840

8

.425

.2300

.2738

-.304

8

.769

-1.6600

5.4655

Step Width

.356

8

.731

.3400

.9555

Step Length

-.305

8

.768

-.9000

2.9492

.129

8

.900

2.80E-02

Speed

~ght

Transfer _

_ ..-

.2169
w

* Indicates data were not normally distributed.
+ Indicates data were significant.
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CHAPTER IV
DISCUSSION
This chapter will discuss the findings of this research study in relation to
previous research of balance retraining of CVA patients with hemiplegia.
Limitations and clinical implications of this study will be addressed with
suggestions for future research being made.
Results
Independent samples t-statistic values indicated that there was no
significant difference between the control and the treatment groups on measures
of static steadiness or symmetry. Significant differences were found between
groups on 2 of the 31 components of dynamic stability tests. These two
components-end-point excursion forward and maximum excursion endpoint forward-were measures of the limits of stability test. Since only 2 of the
total 49 components of balance tests were significant, it was concluded that the
results failed to support the alternate hypothesis which stated that there was a
significant difference between the control and treatment groups on measures of
static steadiness, symmetry, and dynamic stability. Even so, it is difficult to make
conclusions regarding the results of the static steadiness tests, as only one
component of the five met the criteria for a normal distribution.
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Explanation
One possible explanation for these findings involves the chronic,
progressive course of MS. For example, subjective improvements in balance
noted throughout the course of training may not have been demonstrated
objectively during the final assessment secondary to a general decline in
functional mobility. A second explanation is that balance retraining three times
per week for four weeks in addition to regular functions of daily life was simply
over-fatiguing the subjects. Several subjects throughout the course of balance
retraining did indicate that fatigue was making it necessary for them to take more
frequent rest periods during the day. This reported fatigue could negatively
affect the subjects' performance during retraining as well as on the final balance
assessment.
Another factor that could have skewed the balance performance results is
the possibility of non-compliant behavior on the part of the control subjects. It is
probable that one or more subjects in the control group did not follow instructions
to maintain their present lifestyle. In fact, one subject, upon performance of the
final balance assessment, admitted that she had been frequently "practicing" the
balance activities performed in the initial assessment to see if she could
"improve" on the final assessment. The next issue addresses the probability that
the treatment subjects were those who had more severe balance impairments
(either subjectively or objectively) and who chose to be in the treatment group
because of these deficits. The control subjects may have viewed their balance
difficulties as less severe and, therefore, chose to not participate in balance
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retraining. This issue is supported by the fewer numb.er of falls reported by the
control subjects versus those reported by the treatment subjects. Subjects in the
control group reported a mean of 16 falls per year; this compared to a mean of
25 falls per year reported by the treatment subjects. In this scenario, it is
possible that, because of the differences in initial balance performance between
groups, the treatment subjects did improve from initial to final balance
assessments even if these improvements were not observed between groups.
The variable signs, symptoms, and severity of the MS disease among
subjects could have influenced the results of this study. It was difficult, at best,
to make judgments regarding balance performance as a group, when each
subject varies significantly in many areas: strength, range of motion, flexibility,
sensation, tone, endurance, balance strategies, overall functional mobility, visual
deficits, reaction time, and use of assistive devices. The fact that there was no
standard protocol used consistently throughout balance retraining was another
factor that could have affected the results. In addition, the training subjects not
only were trained at different levels according to the limits of stability (LOS)
determined in the warm-up, but also performed various balance retraining
exercises depending on the severity of their balance impairments.
Random selection of subjects and subsequent random placement of each
subject into either the control or treatment group may have resulted in more
statistically significant findings. The researchers' relative lack of experience
using the NBM® as well as in evaluating and treating persons with MS could have
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further skewed performance measures. Finally, using such a small sample size
(five subjects in each group) could have affected results.
Previous Research
Currently, there is no research available regarding balance assessments
and retraining for persons with MS utilizing a biofeedback force platform system,
such as the NBM®. Therefore, the results of this study will be compared and
contrasted with those from previous studies on balance retraining with
hemiplegics using a biofeedback system. Previous studies have reported that
hemiplegic subjects show more consistent improvement on measures of
dynamic stability than other measures of balance when incorporating feedback
from a platform system. 10 A study by Nichols 10 reported that dynamic stability
and symmetry measures showed consistent improvement in the retraining of
hemiplegic patients using biofeedback. A study by Sackley27 also reported
improvements in symmetry among hemiplegic patients.
The results of this study with MS subjects showed that no significant
differences were found between the control and treatment groups in measures of
symmetry. In regard to dynamic stability, this study showed that significant
differences between groups were found for only 2 of the 31 components of
dynamic stability tests. A study by Shumway-Cook and associates12 indicated
that hemiplegic subjects improved in measures of static stability when trained
with a force platform balance system. Such improvements or differences
between groups were not observed among the MS subjects of this study.

43
The results cited in this discussion were based on studies of the effects of
balance retraining on cerebrovascular accident (eVA) patients with resulting
hemiplegia. A eVA is not a progressive disease; rather, persons having suffered
a eVA have the potential to regain some motor and sensory function as well as
functional mobility. Individuals with MS typically experience a progressive course
and may not regain functional losses. Therefore, any comparisons between the
studies with hemiplegics and this study with MS subjects must be made with
caution.
Limitations of Study
A major limitation of this study is the small sample size utilized for both the
treatment and control groups. For the results of this study to be statistically
significant, a larger group of subjects would need to be utilized. A second
limitation is the diversity of subjects in regard to their MS diagnoses-type, signs
and symptoms, severity, exacerbations/remissions, level of function, and balance
deficits. It is difficult to establish a normative sample when the subjects differ so
greatly.
The researchers should be proficient and well-practiced in the use of this
biofeedback force platform system. Prior to administering the initial balance
assessments and retraining on the NBM®, the researchers involved in this study
each conducted balance assessments on the same three subjects. The results
of these assessments were compared to those of the other two researchers. It
was also required that the researchers perform a variety of the balance retraining
protocols to gain experience as well as to establish a general protocol for the MS
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subjects to follow. This brief training period did allow the researchers to become
more comfortable with the NBM®; however, the researchers were completely
inexperienced in the assessment and retraining of balance in the MS population .
The fact that the subjects were not selected in a random fashion and were
not assigned to groups randomly is yet another shortcoming of this study. For
the results to be truly significant, selection would have been performed in a
random fashion with subsequent random assignment to the treatment or control
group. Another limitation was the limited time frame (four weeks) in which to
carry out retraining sessions and final assessments. Perhaps with a lengthened
training period (six to eight weeks), statistically significant findings would have
been observed with this study. A final limitation was inadequate monitoring of
the control subjects' compliance to maintain their present lifestyle and avoid any
changes in physical activity. It is possible that the researchers were not clear in
regard to these instructions provided during the initial assessment. Regardless,
strict monitoring of control subjects is difficult, at best, especially throughout a
four-week time period and in an outpatient type of setting .
Clinical Implications
Balance is an integral part of a physical assessment for a multitude of
patient diagnoses, including MS. Therefore, the significance of this study
involved the utilization of a biofeedback force platform system to assess and
retrain postural stability for persons with MS in an objective manner. When
individuals with MS demonstrate improvements in balance, they are able to
function more independently and, as a result, gain control over one of the most
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debilitating effects of the MS disease process. Improvements in balance and
functional mobility also improve the person's emotional and social well-being.
Because of the limitations of this study, the results were not as anticipated.
Therefore, this study may be used as a basis for future research incorporating a
larger sample size and/or a greater period of time for balance retraining.
Future Research
Future research should attempt to eliminate the limitations of this study.
Sample size should include more subjects for the data to yield truly statistically
significant results. The subjects should be selected in a random fashion and
assigned to groups accordingly. The researchers should be experienced in
assessment and retraining procedures utilizing the NBM®. It may be of interest
to utilize a longer period of balance retraining for MS subjects in the treatment
group. Studies could be done to determine the effectiveness of balance
retraining using the NBM® for the treatment group versus a home exercise
program of conventional balance exercises for a second treatment group in
comparison to the control group of MS subjects. Researchers could compare
balance performance of persons with MS to the normative data as well as to
establish reliability and validity issues in terms of assessing balance in MS
patients. Studies could compare the NBM®, Tinetti Gait and Balance
Assessment, and Berg balance tests in regard to reliability, validity, and
efficiency of balance assessment in persons with MS.
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Conclusion
As physical therapists, it is important to examine possible therapeutic
treatment modalities that may prove successful in treating various diagnoses,
including MS. Balance impairments are common in persons with MS and are
often treated with medications or conventional balance exercises. Recently,
biofeedback force platform systems-like the NBM®-have been utilized for
balance retraining in persons having suffered cerebrovascular accidents with
resulting hemiplegia as well as for a variety of other neurological and orthopaedic
populations. Force platform studies with hemiplegics have shown varied results;
however, for the most part, some improvements in postural stability have been
observed. 1o,11,22
To date, no research has been conducted using a biofeedback force
platform to assess or retrain balance in persons with MS. Our study investigated
the effects of a balance retraining program with MS subjects utilizing the NBM®
force platform system. Results showed that there were no significant differences
between the control and treatment groups on measures of static stability and
symmetry. Further, only 2 of the 31 components of the dynamic stability tests
showed significant differences between groups. Both components were
parameters of the limits of stability test and measured the distance at which the
initial movement attempt stopped or reversed while moving and the farthest
distance the subject reached while moving forward. This finding tends to support
studies of hemiplegics which showed significant improvements in dynamic
stability. However, the results of this study disagree with those of hemiplegic
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studies that found significant improvements in symmetry and static steadiness.
Again, one should use caution when making comparisons between studies of
balance retraining for persons with hemiplegia and retraining for individuals with
MS.
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Institutional Review Board

Human Subjects Review Form
For new projects or procedural revisions to approved projects involving human subjects.
Jill & Becky, 746-9508 •
Principal Investigator: Biana Zearley, Becky Coy, Jill
Phone#: Biana, 775-1061 Date: 3/26/98
Institution: Uni vers ity of North Dakota
Research Coordinator:
Meri dee Green

Ste'19WSlrfment:

Phys i ca 1 Therapy
Phone #:
777-2831

--~------------------------------------

Proposed Project Dates: __4....:..;/:.-8;:,.:/~9;...:8:----:____-=---::--:-__--=_--::--_ _ _--,-.,_-:-:-__--=-__-=--:-__--:,...,.....-.....,.....__--:-_
Project Title: The Effects of Balance Training Exercises on the NeuroCom Balance Master in
Subjects with Multiple Sclerosis
Funding Agencies 0fapplicable): _______________________________________________________~
Type of Project:

~

New Project
0 Continuation
0 Renewal
0 Student Research Project
o Dissertion or Thesis Research
0 Completed Project
o Reports (Adverse events, deaths. complicationsf
o Amendments or change in project
DissertationlThesis Adviser. or Student Advisor: _..-:...:M::::,.er!-1..:...;·d::,.:e: .,:e=-.. : G:. !.r. .:;:ec:: e.:. :.n____________________________

Proposed Project: 0 Involves New Drugs (IND)
0 Involves Non-Approved Use of Drug
~ Involves a Cooperating
Institution
°0 None of the Above
If any of your subjects fall in any of the following classifications. please indicate the classification:
o Minors « 18 Years)
0 Pregnant Women
0 Mentally Disabled
0 Fetuses
0 Mentally Retarded
o Prisoners
0 Students
0 Abortuses
0 Control Group
If your project involves any human tissue. body fluids. pathological specimens. donated organs, fetal material. or placer
tal materials, check here __ .
_X_ Expedited Review requested under item ~ (number) of HHS Regulations (see attached explanation)
_ _ Exempt Review requested under item
_ _ (number) of HHS Regulations (see attached explanation)
1.

ABSTRACT (Limit to 200 words or less and include justification or necessity for using human subjects. Attach add
tional sheet if necessary.)
Multiple Sclerosis (MS) is the most common demyelinating disease of the central nervo:
system and has been referred to as "the great crippler of young adults.11 The disease
commonly affects individuals between the ages of 20-45 and is more prevalent in the
geographical areas that are farthest from the equator. Hence, the state of North Oak
lies within the "MS belt" and the occurrence of the disease becomes very prevalent in
this area. The symptoms and exacerbations vary greatly among individuals; in additio
the same individual may experience varying signs and symptoms throughout the disease
process. According to Shephard et al, who conducted a study on balance disorders in
MS patients, balance difficulties tend to be a common problem among MS patients.
These difficulties in balance can have severe consequences on an individual IS physica
and psychosocial well-being. Presently, there is no cure for MS, nor is there a
treatment to completely eliminate balance difficulties. However, many patients with
MS undergo inpatient therapy, are on a home exercise program, or use an assistive
device for their balance difficulties. The purpose of this study is to determine i f
balance exercises performed on the NeuroCom Balance Master are effective in improving
balance for individuals with MS.

PAGE 1 C
8012-0001 MAr

PLEASE NOTE:

49

Only Information penlnent to your request to utilize human sublects In your prOject or activity should be included on
this form. Where appropriate attach sections from your proposal Including data collection instruments where applica.
ble.
2.

PROTOCOL: (Descnbe procedures to which humans will be subjected.)

Background and Objectives
Balance difficulties are a common manifestation of multiple sclerosis. These balance
problems are an impairment that may result in a disability or a handicap for the
patient. Patients with MS may receive physical therapy, may perform a home exercise
program, or may use an assistive device for their balance difficulties. The objective
of this study is to determine if an exercise program performed on the NeuroCom
Balance Master can improve balance over a four-week period.
Subjects
Ten subjects will be used in this study. Five will be involved in the control group
and five will comprise the treatment group. All subjects involved in this study will
have MS and will be receiving care under Dr. Teetzen, a neurologist at the Altru
Hospital . . Patients who are ambulatory, otherwise healthy, and have physician approval
will beasked to participate. More specifically, only those patients who are in the
3.0-6.0 category based on the Kurtzke Scale of Multiple Sclerosis Classification will
be asked to participate in this study (see attachment). Each subject will be informed
of the time-frame, procedure, benefits, and risK factors associated with this study.
In addition, all subjects will sign a statement of informed consent.
Instrumentation
The NeuroCom Balance Master has been shown to be a reliable and valid tool in assessin'
balance impairments and in balance retraining in individuals suffering from cerebrovascular accidents, traumatic brain injuries, orthopaedic disorders, or Parkinson's
Disease. There is limited research which utilizes the NeuroCom Balance Master for
balance assessment and training in individuals with MS. Therefore, this research
project will contribute to expanding research in improving balance in the MS populatio;
Inter-reliability and intra-reliability of the researchers was determined prior to
starting the research project by testing three individuals with no experience using thr
NeuroCom Balance Master. Each individual was instructed and tested in four assessment
exercises by the three members of the research team. Due to the high learning curve
associated with the NeuroCom Balance Master, each subject was given one practice trial
of the assessment to become familiar with the machine, and the data associated with tha
assessment was disregarded. Each subject was re-tested two days later to establish
intra-reliability. GOod inter- and intra-reliability was proven by comparing results
between each tester and comparing results from retesting. Validity of the NeuroCom
Balance Master has been established by the ability to obtain objective, quantifiable
measurements from a computerized printout of each assessment. Information in the prinout includes diagrams depicting multi-directional movements, deviations in static
positions, and tables and bar graphs organizing the data results.
Procedure
This study will consist of two groups of subjects, a control group and a treatment
group. All subjects will be given a general evaluation conducted by a member of the
research team and will include testing of general lower limb strength, flexibility,
sensation, and reflexes. Due to a high learning curve, all subjects will be asked to
perform a "trial" initial assessment on the NeuroCom Balance Master. The data obtaine'
in the "trial test" will be disregarded and will be followed by a second initial
assessment that will be recorded. The data will be used to determine each patient's
current balance difficulties and will be used as a comparison tool to data obtained in
the final assessment.
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Procedure (Cont.)
The control group will only be seen twice, initially to be given a general evaluation
by a member of the research team and to perform a "trial" and initial assessment, and
finally to perform the same assessment after a four-week period. The treatment group
will also be given the same general evaluation, "trial," and initial assessment, but
this group will be involved in an exercise protocol on the NeuroCom Balance Master
three times per week for four weeks . The exercise protocol will be the same for each
patient and will only differ in level of difficulty, according to the patient's curren
level of MS. At the end of the four-week period, the treatment group will also perfor'
a final assessment. These data will be compared to the final assessment of the contro
group along with the initial assessment of the treatment group to determine if balance
was improved with the exercise protocol performed on the NeuroCom Balance Master.
Subjects will be given adequate time to complete all that is asked of them during this
study along with appropriate rest periods as determined by the subject. Participation
in the general evaluation conducted by the researcher, the initial and final assessmen
along with the exercise protocol will be pain-free for the patient.
Statistical analysis of the data will consist of descriptive and analytical statistics
A related samples t-test or the most appropriate method of statistical analysis will
be used. All data, questionnaires, and consent forms will be kept in a confidential
file in Meridee Green1s office at the Department-of Physical Therapy, University of
North Dakota and will be kept for a two-year period.
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3.

BENEFITS: (Describe the benefits to the individual or society.)

Due to the small sample size, this study may not show statistical significance;
however, many benefits may still be observed . Upon completion of this study, the
NeuroCom Balance Master will be a possible tool used to assist in recording accurate
and reliable information for assessment and treating balance dysfunction in
individuals with MS. Improvements in balance will increase their functional level
and may promote psychological/social well-being. Findings can be used to develop
a balance protocol for people with MS that may be used in the clinical setting and
can help with support in cost-effective treatment for reimbursement from third
party payers. This study can be a foundation for future research involving more
subjects to establish normative data of balance parameters for individuals with MS
using the NeurCom Balance Master. It will, therefore, contribute to the future for
physical sciences and rehabilitation research.

4.

RISKS: (Describe the risks to the subject and precautions that will be taken to minimize them. The concept of risk
goes beyond physical risk and includes risks to the subject's dignity and self respect, as well as psychological, emotional or behavioral risk. If data are collected which could prove harmful or embarrassing to the subject if associated
with him or her, then describe the methods to be used to insure the confidentiality of data obtained, including plans
for final disposition or destruction, debriefing procedures, etc.)

The risks associated with this study are minimal, but those that do exist will be
controlled. The physical risks include possible loss of balance during the assessment or training on the NeuroCom Balance Master. However, this risk of falling
will be minimized by requiring subjects to wear a gait belt and having at least
two members of the research team spotting during all testing and training procedures.
In addition, verbal instructions will be given to subjects prior to balance
assessment and subsequent training. Also, subjects will be given adequate rest
periods to minimize fatigue.
Risks to the subjects' dignity and self-respect will be accounted for and controlled
by the research team by 1) scheduling indivjdual testing sessions to promote privacy,
2) giving subjects complete instructions regarding their role in the research
project, 3) providing the subjects with a safe and controlled environment in which
to work, 4) informing the subjects that all information pertaining to history,
performance, and functional outcomes will be disclosed with a number and no names
will be used. Finally, the subjects will be notified that they may withdraw from
the study at any time should an exacerbation of symptoms or any other problems arise.
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5.

CONSENT FORM: A copy of the CONSENT FORM to be signed by the subject (if applicable) and/or any statement
to be read to the subject should be attached to this form. If no CONSENT FORM is to be used, document the procedures to be used to assure that infringement upon the subject's rights will not occur.
Describe who will be obtaining consent, where signed consent forms will be kept, and for what period of time.

All consent forms, questionnaires, and data reports will be kept in the Physical
Therapy Office, Room 1518 of the UNO School of Medicine and Health Sciences. Data
and information obtained from the study will be kept in Room 1518 for two years
following the completion of this study. Please see attached consent form.

6.

For FULL IRB REVIEW, forward the
instructions to:

~

original of this completed form and, copies as outlined in the attached

For EXEMPT or EXPEDITED REVIEW forward a
and any supporting documentation to:

~

original and a copy of the consent form, questionnaires, etc.,

Eleanor Tveit, IRB Secretary

1000 South Columbia Road
Grand Forks, ND 58201
701-780-6161

-----~-----------------------------------------------The pOlicies and procedures on Use of Human Subjects in Medical Park Institutions apply to all activities involving use of
Human Subjects performed by personnel conducting such activities. No activities are to be initiated without prior review
and approval of the Medical Park Institutional Review Board .

.g~~

Signatures:

Principal Investigator:

Project Director:

.......;lJI2:=:..L.....,.~""~:::::c.--J:.....-..;.....~_.¥_______

~'4~
~~rL

Student Advisor
(where applicable): "

5-2.(:,-'18
'3 - Z&.- 1<f
Date: ___3,,-/"~~_-_lf_f_____

Date:_3.......1....--.i::....2::..:>.b~~~8:=:.....-_ _ __
-..

Date:_..:::3~-....:.....';2-=-b_-_9_8~_ _ __
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NOTE: EDDS steps 1.0 to 4.5 reter to patients who are fully
3mbufatory. and the Dreclse steD number Is defined by the
.':~"cllona' System score(s). EDSS ~teps 5.0 to 9.5 are defined
'w ihe impaIrment at JmtJulation. and usual equivalents in
;:unctlonal System scores are provided.

o

,'lormal ,1eurologlcal exam (all grade 0 in FS·).

1 'J . ,\10 disability. mrnimal signs in one FS' (i.e.; grade 1).
~ ;5 • ~Jo

.:lisaollit'l. .-:irnlmal sic;ns in more than one FS' (more
'nan one FS grade i).

7.5 - Unaole:o 'ake :nore :han a tew steps: restncted to 'Nheelchair: may need Jld 10 transfer; wneelS self out ~annot carr!
·In in 3:andard ','/neelchalr a full dav; May require :notorrzed
wheelchair; (Usual FS ~quivalents are combinations .vUh
more than FS grade 4+) .

, .:; . "'Iinlmal :J:sacllirj :n :':10 =3 ,.:·,vo ,=S ;Jraae 2. 'JU1ers.J or i 1.

8.0 - Essentially restricted :c jed or chair or perambulated in
wheelchair, but may be out of bed itself much of the day;
;~!arns "r.:!ny 32If-<:are :unctrons: generall" h:Js i!Hec:jl/e :.Ise
1f arms: Js;;al FS =quivalems are comDrnations; ';enerally
'jrJde ~- oil 32'/eral systems).

3.J - ,vladerate disaollit'l in one ::S (one FS grade 3. others 0 or 1)
or .nild r:!isacliil'/n :hree ;r 'our ::S (three 'Jr· four FS grade
2, others 0 'Jr :) :rrrougn :~ily ambulalOrj.

8.5 - :ssentlally restric:ed :0 bed :nuch of day: has some ~f'ecti'le
:.Jse 'Ji Jr:n i, Sj; -:;tains some seif-care iunC:lons: (usual .=3
equivalents are combinations generally 4+ in several systems).

2.':; ..vlinimal disaOilil'1 in one'=S (one FS grade 2, others!):o 1).

C~lIy amoulatory jut with :noderate disaoilil'! in one FS (one
grade 3) and one or two FS grade 2; or two FS grade 3: or
five FS grade 2 (others 0 or 1).

=';11'1 1~:JuIJtcrj .'Jltnou; ::ICl . se!f-sutfic:ent,

Jnd about
30..-:e • 2 ~aurs 1 ".ay desc:!e relativ~ly severe disaoility consisting oi one FS grade 4 ~cthers 0 or 1), or combinations of
'~sser ;rades :xceeding :I:-:~S :;t :Jr~'Iious Sieos: ao1e :0
walk ',vlthout aid Jr ~ast SI: .7.e SCO :r.eters.
:';0

4.5 - Fully ambulalOrj without aid. up and about much of the day,
3ble to 'NarK a full d:!y, :nay Jtr.er'.'Iise ~ave some ;Imitation
if :uil aC:I'IiI'J Jr i:Gulre rr.:r:lmal JSSls:ance; C:larac:emed Jy
relatively severe disability usually consisting of one FS grade
.! . Jthers <] 'Jr 1\ or :ombina:ior.s of lesser gfJdes exceeding
dml!S :i ;Jre'/icus s:~ps: :l:::~ :0 ',valk '-"I!nOut aid or iest
50me 300 meters.

5n .

.\mDl;lat'J~1 ·.'Iltrou~

:lid 0r ~es~ 'G~ }bc:.;: 2~0 r71eters: disaoii':/ S~'1er9 ~~o:.;gh ~o :rr;:air "J;( :lally 'Ic:!'mies i'e.Q .. :0 work
a full day without s~ecial :rJ'/isions); I.lJsual FS equivalems
1re ane lrade 5 alene. J:!"'",~S ] or 1; or combination of less~r ;races '1suail'! ~xcaeci:::;; :~cse tor step 4.0).

5.;.lmoulatar/ without 3id fJr -~st :cr about; 00 :neters: disaoll:lj severe :!nough :0 prec::;de full daily activities: (usual FS
equivalents are one grade 5 ~Ione, others 0 or 1; or combilaten ;i 'esser 'lr;:ides !Js<.lally exceeding those for step 4.0).
n

,:hJlr 'jome !:: nours 1 jay: ,iJsual ;:5 ~quivalents Jre comOInatronsNith :nore 'han one FS Irade ~ ... : 'terl rarely pyrami'JJi l;r:JG~ 5 ..ilcre l.

.

I

..

;,t3r:-;:::3nt .)r "..:nllater,1 ::r.srant assistance ::cane. crutch.
!::raca) ~2qlJir2d :0 ·.'lalk ~::elJt ~ GO :neters with our without
~esting; ~usual FS equivaiEilTS are combinations with more
:han :11'0 FS Jrade 3ot-j.
.

or'

.;:

6.5 - Constant :ilateral assistance (canes, crutches, braces) required
to walk about 20 meters 'IIimaut ~esting; (usual FS equivalents
]:e combinations ',vun :rocr:! :i'1:ln ~NO FS grade 3+).
~i'le meters 2'1en with
lid. ~sscn!ially '9S[ilcted :0 ',vnee!cnair: wheels self in stan:ard 'Nheeichalr Jnd .,anstef, ]Ione: LlC and Jcout in 'Nheel-

-; 'J - Jrable to walk aeyona apcroximately

9,0 - Helpless :Jed patient; can communicate Jnd eat; (;JslJal FS
equivalents are combinations, mostly grade 4+).

9.5 - Totally helpless :Jed patient; :mab!e !O communica:e ~ifec
:;'/ely 'Jr ~arJs'.·/ailow : (~sual ;::S =qwlJalems Jre ,:omClna:ions, almost ail graae 4+).
10.0- <:eathjt;e:o I,lS

Assessment Index

o - Normal .;alt
- Walks r.crmally cut reDor:s fatigue ',vnic!1 interferes '.'lith
demanoing Jc:ivities.
2

3

- Abnormal gait ·Jr aplsoaic :ro.baiar.ce; ;ait Jiscrder ;$ ::oticeable to family; able to walk 25 feet in 10 seconas or less.
Walks incecencemly: 3ble :0 walk 25 fee! ,n 21] seconds 'Cr less.

4

- Requires ~nilatefal SUDDOn: Icane, single ·:rutch) :0 walk;
:.Jses support more :~an 30~/O 01 :::e :i~e. Walks 25 :eet in
20 seconds ar less.

5

Reaulres :::ilateral support ,car.es, c~:;:ches, walker! :Ina
walks 25 feet in 20 seconas or less; or, requires Jnrlateral
support but ',valks 25 reet in graater man 20 seconas.

6

- Requires bilateral support and walks 25 reet in greater than
20 seconds. May use wheelchair on occasion .•

7

Walking limited to several slees ','/Irh jiiateral 5UOpOr:: unable
to walk 25 feet. \1ay ~se wheelchair ior 110St actiVities,

8 - Restricted to wheelchair: able to :ransfer independently.
9 - Restrrcted to wheelchair; unable to transfer independently.
("The use of a wheelchair :nay be determined by a patient'S
lifestyle Jnd motivation.)
Physician Siqnature _______________
Date: _ _ _ _- - - - - - - - - - - - - -

Neurological Assessment
Kurtzke Functional Systems- ecss
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I.

2.

Pyramidal Functions
,)
" Nor:nal
1
Abnormal signs without disability
2 = Minimal disability
3 = ,'.!fild :c moderate paraparesis or hemiparesis; severe
monoparesIs
-1
Marked paraparesis or hemiparesis. moderate quadrinaresls: or monoplegia
5
Paraplegia. hemiplegia or marked quadriparesis
6
Quadriplegia
9 = Unknown
Cerebellar Functions
= ," /ermal
1 = Abnormal signs without disabiiity
2
,\-lild ~:axla
3 = Moderate truncal or limb ataxia
~ = Severe ::itaxla in all limos
5
Unable !o perform coordinated movements due to ataxia
7 = When weakness (graoe 3 or worse on pyramidal)
interferes with testing
9 = Unknown

S.

Bowel and Bladder Functions
= .'lormal
I "M ild unnar/ nesitanc'l. urgency, 'J r retention
2 = Moderate hesltanc'!. urgency. retention ot bowel bladder
or rare urinarl incontinence (imermittent self-cameterizallon, manual compression to emoty bladder. or finger
evacuation of stOOl)
3
Freauent urinar/ incontinence
4
!n need of almost constant catheterization (and constant
use ot measures to evacuate stOOl)
5 " Loss ot bladder function
6
Loss of bowel and bladder function
9
Unknown

o

Q

J.

4.

6.

I = Scatoma with '/isual acuity (correct2d) better :han 20/30
2= 'Norse eye With scotoma with maximal visual acuity
(corrected) ot 20/30 to 20/59
3
Worse eye with large scotoma. or moderate decrease in
fields. but With maximal Visual acuity (corrected) of
20/60 to 20/99
-1 " Worse eye with marked decrease of fields and maximal
'/lsual acuity (correcteo) or 20/1 00 to 0 20/200: grade 3
: ius maximal acuity af better )t 2(::60 Jf less
5
Norse eye with i7:3Xlmal '/lsual aC:Jlty (correcteo) less
:han 20/2CO: grade 4 alus ;.'!aximal acuity better eye of
20/60 or less
6 Grade 5 plus maximal visual Jcuity of better of 20/60 or
;ess
7 = Presence of temporal pallor
9 = Unknown

Brainstem Functions
;',JOimal
1
Signs or.!y
2
:"Icderate nystagmus or other mild disability
3 ,, 'v1oderate n'lstagmus, marked extraocuiar weakness. or
mooerate Qlsaoility Jt cmer Cranial nerves
4 = Marked dysarthria or other marked disability
5 = !naoility :0 swallow or speak
9
Unknown

o

Sensory Functions

o = ;',Iormal

7.

Mood alteration only (does not affect ass score I
Mild decrease in mentation
:\loderare decrease in menta::on
Ivlarked decrease in mentation (chroniC brain
syndrome - moderate)
5 = Dementia or cnronic brain syndrome - severely
incompetent
9 = Unknown

1
2
3
4

iirr.:;s

= ~.1ild

dec~ease :n !ouch or pain or pOSition sense. and/or
moaerate decrease in 'lIb ration in one or ,,vo limbs; or
vibratory (cis figure writing) decrease alone in three or
four limos
3
Moderate decrease in touch or pain or position sense.
and/or essentially lost vibration in one or two limbs; or
mild decrease in :oucn or pain and/or moderate
aecrease in JII proprioceptive tests in three or four limbs
4
Marked decrease in touch or pain or loss of proprioception alone or combined. in one or two limbs; or moderate decrease in touch or pain and/ or severe proprioceptive decrease in more than two limbs
5 = Loss (essentially) of sensation in one or two limbs; or
moderate decrease in touch or pain and/or loss of proprioception for most of the body below the head.
6
Sensation essentially lost below the head
7 = Unknown

Cerebral (or Mental) Functions

a = ~Jormal

= Vibration or figure-writing decrease only in one or two

2

Visual (or Optic) Functions

o = ,'Iormal

a.

Other Functions
a. = Spasticily
o " None
1
Mild
2 = Moderate - (minor interference)
3 = Severe - (major interference)
9 = Unknown
b. = Others
o = None
I = Any other neurological findings attribute MS: Specify
o = Ur.known

Neurological Assessment
Kurtzke Functional Systems - ECSS

~d!!'ru
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INFORMATION AND CONSENT FORM #1
TITLE: The Effects of Balance Training Exercises
Subjects with Multiple Sclerosis.

Oil

the NeuroCom Balance Master ill

You are invited to participate in a study conducted by Becky Coy, Jill Steinmetz, and Biana
Zearley, physical therapy students at the University of North Dakota. The purpose of this study is
to determine if balance exercises performed on the NeuroCom Balance Master, a machine used to
assess balance, are effective in improving balance for an individual with Multiple Sclerosis (MS).
Only subjects with MS who are otherwise normal and healthy and have physician approval will be
asked to participate.
You will be asked to report to the Physical Therapy Department at the Altru Health Institute
Rehabilitation Hospital where a general assessment will be conducted by a member of the research
team. We ask that you wear loose,comfortable clothing and tennis shoes when participating in
this study. The assessment will include: general lower limb strength, flexibility, sensation, and
reflex testing. We will be recording your name, height, and date of birth (all will be
confidential). You will be asked to complete a questionnaire concerning balance difficulties,
current exercise routine, activities of daily living, and whether or not you use an assistive device
for ambulation. You will then be asked to participate in a "practice trial" assessment on the
NeuroCom Balance Master which will take approximately 15 minutes. Following this, you will be
asked to perform a series of tests on the machine (the actual assessment) and this will take
approximately 30 minutes.
You will be asked to return to the Altru Health Institute Rehabilitation Hospital fourweeks from
the initial evaluation, it is at this time that a fmal evaluation will be conducted involving the same
tests as before. We ask that you continue to assume you regular levels of exercise and activities
of daily living during the four week period.
Dr. Teetzen will be overseeing this study and two members of the research team will be present at
all times. Throughout the experiment, we will use the NeuroCom Balance Master as an
assessment and training tool. This machine is commonly used in physical therapy clinics across
the nation and is a clinically accepted measure of balance.
The results from the study will be confidential and your data will be identified by a number known
only by the investigators. Whether or not you decide to participate in this study will not
jeopardize your future relationship with the Physical Therapy Department or the University of
North Dakota. If you decide to participate, you are free to discontinue participation at any time.
The investigators involved are available to answer any current or prospective questions you have
concerning this study. Questions may be answered by calling Becky or Jill at (701) 746-9508 or
Biana at (701) 775-1061. A copy of this consent form is available to all participants in the study.
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In the event that this research activity (which will be conducted at the Altru Heath Institute
Rehabilitation Hospital) results in a physical injury, medical treatment will be available, including
fIrst aid, emergency treatment and follow-up care as it is to members of the general public in
similar circumstances. Payment for any such treatment must be provided by you and your third
party payer, if any.

ALL OF MY QUESTIONS HAVE BEEN ANSWERED AND I AM ENCOURAGED TO
ASK ANY QUESTIONS THAT I MAY HAVE CONCERNING TIllS STUDY IN THE
FUTURE. MY SIGNATURE INDICATES THAT, HAVING READ THE ABOVE
INFORMATION, I HAVE DECIDED TO PARTICIPATE IN THE RESEARCH
PROJECT.
I have read all of the above and willingly agree to participate in this study explained to me by
Becky Coy, Jill Steinmetz, and Biana Zearley.

Participant's Signature

Witness (not the scientist)

Date

Date
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INFORMA nON AND CONSENT FORM #2

TITLE: The Effects of Balance Training Exercises on the NeuroCom Balance Master in
SUbjects with Multiple Sclerosis.
You are invited to participate in a study conducted by Becky Coy, Jill Steirunetz, and Biana
Zearley, physical therapy students at the University of North Dakota. The purpose of this study is
to detennine ifbalance exercises performed on the NeuroCom Balance Master, a machine used to
assess balance, are effective in improving balance for an individual with Multiple Sclerosis (MS).
Only subjects with MS who are otherwise normal and healthy and have physician approval will be
asked to participate.
You will be asked to report to the Physical Therapy Department at the Altru Health Institute
Rehabilitation Hospital where a general assessment will be conducted by a member of the research
team. We ask that you wear loose, comfortable clothing and tennis shoes when participating in
this study. The assessment will include: general lower limb strength, flexibility, sensation, and
reflex testing. We will be recording your name, height, and date of birth (all will be
confidential). You will be asked to complete a questionnaire concerning balance difficulties,
current exercise routine, activities of daily living, and whether or not you use an assistive device
for ambulation. You will then be asked to participate in a "practice trial" assessment on the
NeuroCom Balance Master which will take approximately 15 minutes. Following this, you will be
asked to perform a series of tests on the machine (the actual assessment) and this will take
approximately 30 minutes.
Your participation in the study will involve an exercise program that will be conducted on the
NeuroCom Balance Master three days a week for four weeks, each session lasting approximately
30 minutes. At the end of the four weeks, an initial evaluation will be conducted to determine the
effects of the program on balance. We (the researchers) respect your time and realize this is a big
commitment, however, we believe there will be significant improvements in balance and well
worth your time and ours.
Dr. Teetzen will be overseeing this study and two members of the research team will be present at
all times. Throughout the experiment, we will use the NeuroCom Balance Master as an
assessment and training tool. This machine is commonly used in physical therapy clinics across
the nation and is a clinically accepted measure of balance.
The results from the study will be confidential and your data will be identified by a number known
only by the investigators. Whether or not you decide to participate in this study will not
jeopardize your future relationship with the Physical Therapy Department or the University of
North Dakota. If you decide to participate, you are free to discontinue participation at any time.
The investigators involved are available to answer any current or prospective questions you have
concerning this study. Questions may be answered by calling Becky or Jill at (701) 746-9508 or
Biana at (701) 775-1061. A copy of this consent form is available to all participants in the study.
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In the event that this research activity (which will be conducted at the Altru Heath Institute
Rehabilitation Hospital) results in a physical injury, medical treatment will be available, including
first aid, emergency treatment and follow-up care as it is to members of the general public in
similar circumstances. Payment for any such treatment must be provided by you and your third
party payer, if any.

ALL OF MY QUESTIONS HAVE BEEN ANSWERED AND I AM ENCOURAGED TO
ASK ANY QUESTIONS THAT I MAY HAVE CONCERNING THIS STUDY IN THE
FUTURE. MY SIGNATURE INDICATES THAT, HAVING READ THE ABOVE
INFORMATION, I HAVE DECIDED TO PARTICIPATE IN THE RESEARCH
PROJECT.
I have read all of the above and willingly agree to participate in this study explained to me by
Becky Coy, Jill Steinmetz, and Biana Zearley.

Participant's Signature

\Vitness (not the scientist)

Date

Date

APPENDIX D

62
Questionnaire

Name:
Date:

1. Are your balance difficulties?
non-existent

mild moderate

severe

2. How many times have you fallen? Did you sustain an injury, if
so please describe it?
in last month?
in last year?
ever?
3. Have you had any previous hospitalizations or surgeries?

4. Do you have any health problems (beyond MS) we should be aware of?

5. Are you taking any medications?

6. How would you describe the sensation in your feet?

7. Do you have any difficulties with vision?
8. How many days/week do you exercise, what type of exercise do you perform
(walking, riding bike, treadmill)?

9. What do you do during the day (work, stay home, etc.)?

10. Do you use an assistive device for ambulation, if so what?
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MULTIPLE SCLEROSIS INITIAL EVALUATION
Subjects name:
Age:
Height:
MMT:
Sitting
Hip flexion
Knee extension
Knee flexion
Ankle OF
Supine
Hip abduction
Hip adduction
Prone
Hip extension
ROM
Supine
Hip flexion
Knee flexion
Sitting
Knee extension
Ankle OF
Ankle PF
Reflexes
Patella
Achilles
Sensation
Oermatomes
L1 inferior to inguinal ligament
L2 anterior thigh
L3VMO
L4 dorsum of 151 metatarsal/medial side of foot
L5 dorsum of foot
S1 lateral foot
S2 heel
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Glossary:
1. COG sway velocity: Ratio of the distance traveled by the COG around the
center of foot support, expressed in degrees per second.
2. Directional control: Comparison of the amount of movement in the
intended direction compared to the extraneous movement, expressed as a
percentage.
3. Endpoint excursion: Distance traveled by the COG on the primary attempt
to reach the target expressed in percent LOS. The endpoint is considered to
be the point at which the initial movement ceases and corrective movement
begins.
4. End Sway: The amount of sway occurring after changing from a dynamic to
a static position.
5. Impact index: The average maximum force transmitted through the lagging
leg as it lands on the surface, expressed a percentage of body weight.
6. Impact index difference: A comparison of the mean amount of force
transmitted through the left and right legs, expressed as percentage.
7. Left/right weight symmetry: The percentage of weight borne by each leg
during static and dynamic activities.
8. Lift-up index: The average maximum force exerted by the step-up leg,
expressed as a percentage of body weight.
9. Lift-up index difference: A comparison of the mean amount of force
exerted by the left and right legs, expressed as a percentage.
10. Maximum excursion: Furthest distance traveled by the COG during the
trial, expressed as a percentage.
11. Mean rising index: The average amount of force exerted by the legs during
the rising phase, expressed as a percentage of body weight.
12. Mean weight transfer: The average amount of time between the onset of
the cue to move and the arrival of the COG over the feet, expressed in
seconds.
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13. Movement time: The average amount of time to complete the step up/over
task, expressed in seconds. Scoring begins with the initial COG shift with
the non-stepping leg, and ends with the impact of that leg on the surface.
14. Movement time difference: A comparison of the mean movement times
over the left and right legs, expressed as a percentage.
15. Movement velocity: Average speed of COG movement expressed in
degrees per second.
16. On-axis velocity: The average COG movement speed in the intended
direction, expressed in degrees per second.
17. Reaction time: Time in seconds between signal to move and initiation of
movement.
18. Speed: The rate of ambulation measured in centimeters.
19. Step length: Distance between heel contact of one foot to the contralateral
foot during ambulation measured in centimeters.
20. Step width: Distance between the feet during ambulation in centimeters.
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